EUVIMEDEUVIMED entdecken
Leserbrief

Why does Pakistan lag in the use of fibrinolytics in patients with ischemic stroke?

Muhammad Ahsan, Taher Janoowala, Tehreem Farooq, Ali Ahmad

Eastern Mediterranean Health Journal · 03.08.2026 · 32 (7) · 480-481

DOI: 10.26719/2026.32.7.480 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Eastern Mediterranean Health Journal, online erschienen am 03.08.2026. Verfasst von Muhammad Ahsan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jinnah Sindh medical University, Karachi, Pakistan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Pakistanalteplasefibrinolyticshealth systemischemic stroketenecteplase

Autor:innen und Institutionen

  • Jinnah Sindh medical University, Karachi, Pakistan.
  • lmam Clinic, Karachi, Pakistan.
  • Jinnah Postgraduate Medical Center, Karachi, Pakistan.

Zitieren

APA

Ahsan, M., Janoowala, T., Farooq, T., & Ahmad, A. (2026). Why does Pakistan lag in the use of fibrinolytics in patients with ischemic stroke?. Eastern Mediterranean Health Journal, 32(7), 480-481. https://doi.org/10.26719/2026.32.7.480

Vancouver

Ahsan M, Janoowala T, Farooq T, Ahmad A. Why does Pakistan lag in the use of fibrinolytics in patients with ischemic stroke?. Eastern Mediterranean Health Journal. 2026;32(7):480-481. doi:10.26719/2026.32.7.480

BibTeX
@article{Ahsan2026,
  author = {Ahsan, Muhammad and Janoowala, Taher and Farooq, Tehreem and Ahmad, Ali},
  title = {Why does Pakistan lag in the use of fibrinolytics in patients with ischemic stroke?},
  journal = {Eastern Mediterranean Health Journal},
  year = {2026},
  volume = {32},
  number = {7},
  pages = {480--481},
  doi = {10.26719/2026.32.7.480}
}
Kostenlos starten →